Showing results (211-220 of 280) with videos related to

Sort By:
Pageof 28
The American Journal of Tropical Medicine and Hygiene|September 30, 2025
IgM, IgG, and IgG Subclass Antibody Responses to Plasmodium falciparum Proteins in Naïve, Malaria-Vaccinated and Semi-Immune Volunteers after Controlled Human Malaria InfectionGloria P Gómez-Pérez, Marta Vidal, Joseph J Campo, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 3, 2025
1.6-Inch Transparent Micro-Display with Pixel Circuit Integrated microLED Chip Array by Misalignment-Free TransferKyungwook Hwang, Junsik Hwang, Yongchan Kim, et al.
The Lancet. Infectious Diseases|April 2, 2017
DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infectionMihály Sulyok, Thomas Rückle, Alexandra Roth, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
CD4 + T cells promote fibrosis during metabolic dysfunction-associated steatohepatitisLucía Valenzuela-Pérez, Hyun Se Kim Lee, Rachel L Bayer, et al.
Nature Communications|December 15, 2025
Mitochondrial RNA cytosolic leakage drives the SASPStella Victorelli, Madeline Eppard, Hélène Martini, et al.
Cell Reports|June 15, 2025
Staphylococci in high resolution: Capturing diversity within the human nasal microbiotaAnna Cäcilia Ingham, Duncan Y K Ng, Søren Iversen, et al.
Plos Pathogens|June 24, 2026
Predictive value of PfEMP1 antibody profiles for the course of controlled human malaria infectionsYannick D Höppner, Ralf Krumkamp, Hikaru Nagaoka, et al.
The American Journal of Tropical Medicine and Hygiene|December 21, 2017
Impact of Sickle Cell Trait and Naturally Acquired Immunity on Uncomplicated Malaria after Controlled Human Malaria Infection in Adults in GabonBertrand Lell, Benjamin Mordmüller, Jean-Claude Dejon Agobe, et al.
Nature Communications|June 18, 2024
Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptomsPatricia Ferrer, Andrea A Berry, Allison N Bucsan, et al.
Eclinicalmedicine|August 5, 2022
PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trialDrissa Coulibaly, Abdoulaye K Kone, Karim Traore, et al.
Pageof 28